2007
DOI: 10.1093/ejo/cjm064
|View full text |Cite
|
Sign up to set email alerts
|

The effects of TBC3214, a selective endothelin ETA receptor antagonist, on orthodontic tooth movement in rats

Abstract: Many chemical messengers are involved in the process of alveolar bone and periodontal ligament remodelling during orthodontic tooth movement. Among them is probably endothelin-1 (ET-1). Its role in this process has been partly explained using tezosentan, which affects endothelin A (ET(A)) and endothelin B (ET(B)) receptors. Tezosentan enhances orthodontic tooth movement. The aim of this study was to determine the possible effects of a highly selective ET(A) antagonist on orthodontic tooth movement in rats. Thi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2008
2008
2016
2016

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(6 citation statements)
references
References 25 publications
0
6
0
Order By: Relevance
“…To better define the exact timing of Ednra action, we took a second approach, in which Ednra signaling was blocked for short periods during development using an Ednra-specific antagonist (Padilla et al, 2006; Sprogar et al, 2007). The antagonist, TBC3214 (Encysive Pharmaceuticals), is an orally-bioavailable non-peptidic antagonist with a sub-nanomolar IC 50 (Wu et al, 2001).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…To better define the exact timing of Ednra action, we took a second approach, in which Ednra signaling was blocked for short periods during development using an Ednra-specific antagonist (Padilla et al, 2006; Sprogar et al, 2007). The antagonist, TBC3214 (Encysive Pharmaceuticals), is an orally-bioavailable non-peptidic antagonist with a sub-nanomolar IC 50 (Wu et al, 2001).…”
Section: Resultsmentioning
confidence: 99%
“…First, we have used a mouse strain carrying a conditional mutation in the Ednra gene (Kedzierski et al, 2003), and crossed these mice with two Cre transgenic mouse lines in which Cre expression in NCCs occurs between E8.25 and E9.5. In a second approach, we have used an Ednra-specific antagonist (Padilla et al, 2006; Sprogar et al, 2007; Wu et al, 2001) to knockdown Ednra signaling at specific time periods of NCC development. Our results indicate that Ednra signaling is required for NCC development in a very narrow temporal window spanning approximately 18 h. In addition, detailed analysis of aberrant craniofacial structures observed following reduction in Ednra signaling in both strains suggest a role for Ednra signaling in the evolution of the mammalian hearing apparatus.…”
Section: Introductionmentioning
confidence: 99%
“…2,5,7,8,10,13,[26][27][28] For the orthodontic movement to be efficient, some variables are essential, including the magnitude and duration of the force and the morphology and alveolar bone density. 1 In our study, the initial force (40 g/F) was applied continuously to induce more tooth movement.…”
Section: Discussionmentioning
confidence: 99%
“…In Group III (n = 7) no appliance was used and the rats were treated daily with saline (1 ml/kg i.p.). A superelastic closed coil spring (25 cN, wire diameter 0.15 mm, GAC International, New York, USA) was placed between the fi rst maxillary molar and the incisors [5]. It was fi xed to the upper left fi rst molar with a stainless steel ligature wire (diameter 0.25 mm, Dentaurum, Ispringen, Germany) and to the incisors by surgical steel wire (4-0, multifi lament, W310, Ethicon, Johnson&Johnson, New Jersey, USA).…”
Section: Methodsmentioning
confidence: 99%